Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study
To access this article, please choose from the options below
PII: S0167-5273(07)00928-X
doi:10.1016/j.ijcard.2007.04.040
© 2007 Elsevier Ireland Ltd. All rights reserved.
